Furthermore, the marked increase in IFN-γ and granzyme B secretion by splenocytes from MNEV-immunized mice underscores the vaccine’s capacity to stimulate cytotoxic T-cell activity, a critical mechanism for tumor cell elimination. The gene discussed is IFNG; the disease is neoplasm.